CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Derivatives Options or other derivatives
- SC 13D Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Former 10% Owner disposed of 8,662,346 shares (other)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 4 Open-market sale See Remarks sold 39,442 shares at $10.71 ($422,282)
- 4 Option exercise See Remarks acquired 10,020 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 21 of 28 · 558 filings